Monameda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 508,311 | 1,271,409 | 1,672,310 | 1,648,470 | 1,778,629 | 2,126,930 | 2,639,951 | 3,485,683 |
| Profit before tax | 438 | 170,915 | 227,418 | 289,481 | 172,186 | 192,906 | 378,718 | 316,783 |
| Net profit | 409 | 145,794 | 194,259 | 247,519 | 148,557 | 166,476 | 325,502 | 269,523 |
| Equity | 30,605 | 176,399 | 300,658 | 428,177 | 376,734 | 493,171 | 818,673 | 988,196 |
| Liabilities | 168,723 | 389,334 | 288,921 | 212,353 | 622,405 | 659,815 | 578,846 | 764,986 |
| Non-current assets | 76,564 | 254,475 | 286,622 | 243,909 | 434,059 | 600,280 | 722,176 | 736,686 |
| Current assets | 122,764 | 311,258 | 302,957 | 396,621 | 565,080 | 552,706 | 676,067 | 1,007,919 |
| Total assets | 199,328 | 565,733 | 589,579 | 640,530 | 999,139 | 1,152,986 | 1,398,243 | 1,744,605 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 514,043 | 600,395 | 855,017 |
| Social insurance contributions | - | - | - | - | - | 78,095 | 75,131 | 102,446 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -2.5% | +150.1% | +31.5% | -1.4% | +7.9% | +19.6% | +24.1% | +32.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.2% | 25.8% | 32.9% | 38.6% | 14.9% | 14.4% | 23.3% | 15.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 1.3% | 82.7% | 64.6% | 57.8% | 39.4% | 33.8% | 39.8% | 27.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.1% | 11.5% | 11.6% | 15.0% | 8.4% | 7.8% | 12.3% | 7.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.1% | 13.4% | 13.6% | 17.6% | 9.7% | 9.1% | 14.3% | 9.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 5.5 | 2.2 | 1.0 | 0.5 | 1.7 | 1.3 | 0.7 | 0.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 81,330 | 211,902 | 286,683 | 329,694 | 304,910 | 344,906 | 377,136 | 422,507 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Monameda - Social security debts
The company had no debts to Sodra
Monameda - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Monameda, UAB (code 126408729) is a Private Limited Liability Company engaged in wholesale of pharmaceutical and medical goods. In 2025, revenue increased to €3.49M, up 32.0% year on year and 63.9% over two years. Net profit was €269.5K, below the €325.5K achieved in 2024 but above €166.5K in 2023, while the profit margin remained at 7.7% after 12.3% in 2024 and 7.8% in 2023. The balance sheet expanded further: total assets reached €1.74M, equity €988.2K and liabilities €765.0K. Equity represented 56.6% of assets, with a debt-to-equity ratio of 0.77. Return on equity was 27.3% and return on assets 15.4%, with asset turnover at 2.00x. Revenue per employee was €435.7K and profit per employee €33.7K. Overall, the company showed strong sales growth, improved scale and a stable capital structure in 2025.